Skip to main content
. 2021 Apr 19;72(5):605–613. doi: 10.1016/j.bjane.2021.03.011

Table 5.

Description of patients with severe neuraxis complications.

Age ASA-PS / Relevant medical history Surgery Anesthetic technique/Number of attempts EC length of stay (days) Symptoms (days after EC placement) EC tip – Microbiologic study Treatment
Epidural abscess 39 II /Inflammatory Bowel Disease Major digestive Lumbar Epidural / 3 3 Spinal pain and fever (D4), sensory deficit (D12) MRSA Antibiotic and neurosurgical decompression
65 IV / Heart Transplant; DM Major orthopedic Lumbar CSE / 4 13 Spinal pain (D13), sensory and motor deficits (D33) MRSA
61 II / Prostate cancer; DMa Peripheral vascular Lumbar CSE/ 3 6 Spinal pain and fever (D11) Negative
Subcutaneous cell tissue hematoma 62 III / DM; HF Major orthopedic Lumbar CSE/1 16 Spinal pain and inflammatory signs (D11) Negative Antibiotic
70 III / CRD; HF Major orthopedic Lumbar CSE/ 1 5 Spinal pain and inflammatory signs (D14) MRSA Antibiotic
62 III/ Epilepsy; Malignant disease Major digestive Lumbar Epidural / 2 4 Sensory and motor deficits (D4) Not applicable Surveillance
Arachnoiditis 69 III / Obesity Peripheral vascular Lumbar CSE / 3 5 Spinal pain and sensory deficits (D13) Negative Antibiotic

ASA-PS, American Society of Anesthesiologists Physical Status; CRD, chronic renal disease; CSE, combined spinal epidural; DM, diabetes mellitus; EC, epidural catheter; HF, heart failure; MRSA, methicillin-resistant staphylococcus aureus.

a

Patient with Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia sepsis.